Skip to main content

Table 1 Characteristics of the patient cohort

From: The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes

Age at surgery (y):   
 Median/range: 66/34–82  
  n = 175 %
Sex:   
 Male: 95 54.3
 Female: 80 45.7
Smoking history:   
 Current: 107 61.1
 Former: 57 32.6
 Never: 11 6.3
Weight loss:   
 No weight loss: 48 27.4
 Weight loss < 10 % 99 56.6
 Weight loss ≥ 10 % 22 12.6
 No data: 6 3.4
Tumor size:   
  < 3 cm 99 56.6
  > 3 cm - ≤5 cm 55 31.4
  > 5 cm- ≤7 cm 19 10.9
  > 7 cm 2 1.1
Stage:   
 I: 97 55.4
 II: 55 31.4
 IIIa: 23 13.1
Histology:   
 Adenocarcinoma: 99 56.6
 Squamous cell carcinoma: 44 25.1
 Other: 32 18.3
EGFR:   
 EGFR mutated: 13 7.4
 EGFR not mutated: 159 90.9
 EGFR not tested: 3 1.7
Chemotherapy:   
 Adjuvant chemotherapy: 54 30.9
 Neoadjuvant chemotherapy: 3 1.7
 No chemotherapy: 116 66.3
 No data: 2 1.1
Radiotherapy:   
 Adjuvant or neoadjuvant: 9 5.1
 No radiotherapy 166 94.9
Status at 5 year follow up:   
 Alive with no disease: 81 46.3
 Alive with disease: 8 4.6
 Dead: 86 49.1
Cause of death (n = 86):   
 Lung cancer: 48 55.8
 Cardiovascular disease: 15 17.4
 Other: 23 26.7